UroGen Pharma (URGN) Capital Leases (2023 - 2026)
UroGen Pharma (URGN) recorded Capital Leases of $2.94 million in Q2 2026.
Powered by 
Analysis
UroGen Pharma (URGN) Capital Leases (2023 - 2026) Analysis & Trends
At the end of FY2025, UroGen Pharma reported Capital Leases of $3.48 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | UroGen Pharma | 1.24 Bn | 782.15 Mn | 81.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.59 Mn |
| Jun 30, 2026 | 2.94 Mn |
| Mar 31, 2026 | 3.16 Mn |
| Dec 31, 2025 | 3.48 Mn |
| Sep 30, 2025 | 3.57 Mn |
| Jun 30, 2025 | 2.86 Mn |
| Mar 31, 2025 | 2.84 Mn |
| Dec 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 844,000.00 |
API Access
UroGen Pharma Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();